Prophylactic mastectomy in women at high risk for breast cancer: Indications and options;Prophylaktische mastektomie bei frauen mit hohem brustkrebsrisiko: Indikationen und alternativen

Handchirurgie Mikrochirurgie Plastische Chirurgie

Volumn 40, Issue 4, 2008, Pages 239-247

  Scheufler, O ^a   Von Fritschen, Uwe ^a  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

BRCA; Breast cancer; Familiar accumulation; Hereditary; Prophylactic; Subcutaneous mastectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; GENE MUTATION; HEREDITY; HETEROZYGOTE; HUMAN; MASTECTOMY; OVARIECTOMY; OVARY CANCER; PATIENT DECISION MAKING; PREGNANCY; PREMENOPAUSE; PROPHYLAXIS; RISK REDUCTION; SALPINGECTOMY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST IMPLANTS; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FALLOPIAN TUBES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; MAMMAPLASTY; MASTECTOMY; MASTECTOMY, SUBCUTANEOUS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS; SURGICAL FLAPS;

EID: 51649083226     PISSN: 07221819     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038774     Document Type: Article

References (52)

1. Al-Ghazal SK, Blamey RW: Subcutaneous mastectomy with implant reconstruction: cosmetic outcome and patient satisfaction. Eur J Surg Oncol 2000; 26: 137-141
2. Bartetzko CL: Subcutaneous mastectomy, a prophylactic operation in breast diseases. Asthet Med (Berl) 1968: 17: 211-214
3. Barton Jr FE, English JM, Kingsley WB, Fietz M: Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg 1991: 88: 389-392
4. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89: 227-238
5. Bloodgood JC: The remaining breast after radical removal of the opposite side for carcinoma. Trans Southern Surg Assoc 1921; 34: 223-241
6. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, Parazzini F, Greggi S, La Vecchia C: Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002; 102: 262-265
7. Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, van Geel AA, Menke M, Verhoog LC, van den Ouweland A, Obdeijn IM, Klijn JG; Rotterdam Committee for Medical and Genetic Counseling: Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001; 19: 924-930
8. Bresser PJ, Seynaeve C, van Goal AR, Brekelmans CT, Meijers-Heijboer H, van Geel AN, Menke-Pluijmers MB, Duivenvoorden HJ, Klijn JG, Tibben A: Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 2006; 117: 1675-1682
9. Claus EB, Schildkraut JM, Thompson WD, Risch NJ: The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318-2324
10. Contant CM, Menke-Pluijmers MB, Seynaeve C, Meijers-Heijboer EJ, Klijn JG, Verhoog LC, Tjong Joe Vai R, Egermont AM, van Geel AN: Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at heteditary risk of breast cancer (HB[O]C) or a proven BRCA 1 and BRCA 2 germ-line mutation. Eur J Surg Oncol 2002;28:627-632
11. Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T. Neuhausen SL, Ghadirian P, Foulkes WE, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA: Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 2005; 23: 7491-7496
12. Eldar S, Meguid MM, Beatty JD: Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 1984; 148: 692-693
13. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risk of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-695
14. Freeman BS: Technique of subcutaneous mastectomy with replacement; immediate or delayed. Br J Plast Surg 1969; 22: 161-166
15. Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM: Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 2007;14:686-694
16. Gerber B, Krause A, Reimer T, Müller H, Küchenmeister I, Makovitzky J, Kundt G, Friese K: Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 2003; 238: 120-127
17. Goodnight Jr JE, Quagliana JM, Morton DL: Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 1984; 26: 198-201
18. Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group: Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 2006; 118: 2281-2284
19. Gui GP, Behranwala KA, Abdullah N, Seet J, Osin P, Nerurkar A, Lakhani SR: The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction. Br J Plast Surg 2004; 57: 146-149
20. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Eng J Med 1999; 340: 77-84
21. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93: 1633-1637
22. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002; 346: 1609-1615
23. Klamer TW, Donegan WL, Max MH: Breast tumor incidence in rats after partial mammary resection. Arch Surg 1983; 118: 933-935
24. Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000; 215: 267-279
25. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF: The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002; 20: 2310-2318
26. Loman N, Johannsson O, Bendahl PO, Borg A, Fernö M, Olsson H: Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 1998; 83: 310-319
27. Lynch HT, Krush AJ: Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 1971; 133: 644-648
28. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA 1 or BRCA 2 mutation. N Engl J Med 2001; 345: 159-164
29. Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG: Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 2003; 21: 1675-1681
30. Mendez-Fernandez MA, Henly WS, Geis RC, Schoen FJ, Hausner RJ: Paget's disease of the breast after subcutaneous mastectomy and reconstruction with a silicone prosthesis. Plast Reconstr Surg 1980; 65: 683-685
31. Metcalfe KA, Semple JL, Narod SA: Time to reconsider subcutaneous mastectomy for breast-cancer prevention? Lancet Oncol 2005; 6: 431-434
32. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71
33. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI: Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005; 294: 1925-1933
34. Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet JS, Ponder BA: Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 1998; 339: 424-428
35. Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. A case-control study. Lancet 2000; 356: 1876-1881
36. Pennisi VR, Capozzi A: Subcutaneous mastectomy: an interim report on 1244 patients. Ann Plast Surg 1984; 12: 340-347
37. Phillips KA, Glendon G, Knight JA: Putting the risk of breast cancer in perspective. N Engl J Med 1999; 340: 141-144
38. Press N, Reynolds S, Pinsky L, Murthy V, Leo M, Burke W: "That's like chopping off a finger because you're afraid it might get broken": disease and illness in womens's views of prophylactic mastectomy. Soc Sci Med 2005; 61: 1106-1117
39. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group: Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 2002; 246: 1616-1622
40. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F: Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 2006; 119: 2417-2422
41. Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Layde PM: Family history and the risk of breast cancer. JAMA 1985; 253: 1908-1913
42. Schrag D, Kuntz KM, Garber JE, Weeks JC: Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336: 1465-1471
43. Spear SL, Carter ME, Schwarz K: Prophylactic mastectomy: indications, options, and reconstructive alternatives. Plast Reconstr Surg 2005; 115: 891-909
44. Stolier AJ, Wang J: Terminal duct lobular units are scarce in the nipple: Implications for prophylactic nipple sparing mastectomy. Ann Surg Oncol 2008; 15: 438-442
45. Temple WJ, Lindsay RL, Magi E, Urbanski SJ: Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer. Am J Surg 1991: 161: 413-415
46. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL: Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 2000; 67: 841-850
47. Van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA: Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 2005; 93: 287-292
48. Wickman M, Sandelin K, Arver B: Technical aspects and outcome after prophylactic mastectomy and immediate breast reconstruction in 30 consecutive high-risk patients. Plast Reconstr Surg; 2003; 111: 1069-1077
49. Wong JH, Jackson CF, Swanson JS, Palmquist MA, Oyama AA, Miller SH, Fletcher WS: Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. Surgery 1986; 99: 67-71
50. Woods JE, Arnold PG, Fisher J, Irons GB, Jackson IT: Subcutaneous mastectomy in the treatment of breast disease. Am J Surg 1983; 146: 683-684
51. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-792
52. Young MO: Prophylactic simple mastectomy. Rocky Mt Med J 1966; 63: 31-32